First, we treated mice with a neutralizing anti-CD115 antibody, which has been shown to alter the differentiation of tumor-associated macrophages due to impaired CSF1/CSF1R signaling, without modifying monocytes in the circulation30. The gene discussed is CSF1R; the disease is neoplasm.